Translational Development... (TDACU)
Translational Development Acquisition Statistics
Share Statistics
Translational Development Acquisition has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1.76K |
| FTD / Avg. Volume | 6.58% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -83.49 and the forward PE ratio is null. Translational Development Acquisition's PEG ratio is -0.14.
| PE Ratio | -83.49 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -79.86 |
| P/FCF Ratio | -198727.94 |
| PEG Ratio | -0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Translational Development Acquisition Corp..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of -0.68.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | -0.68 |
| Total Debt / Capitalization | -216.97 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.96% and return on capital (ROIC) is 0%.
| Return on Equity (ROE) | 0.96% |
| Return on Assets (ROA) | -240.25% |
| Return on Capital (ROIC) | 0% |
| Revenue Per Employee | $undefined |
| Profits Per Employee | $undefined |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -44.74% in the last 52 weeks. The beta is 0.09, so Translational Development Acquisition's price volatility has been higher than the market average.
| Beta | 0.09 |
| 52-Week Price Change | -44.74% |
| 50-Day Moving Average | 10.1 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 45.34 |
| Average Volume (20 Days) | 26.8K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -485.55K |
| EBITDA | -485.55K |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 2.02K in cash and 347.5K in debt, giving a net cash position of -345.48K.
| Cash & Cash Equivalents | 2.02K |
| Total Debt | 347.5K |
| Net Cash | -345.48K |
| Retained Earnings | -532.66K |
| Total Assets | 58.4M |
| Working Capital | -10.22M |
Cash Flow
In the last 12 months, operating cash flow was -204 and capital expenditures 0, giving a free cash flow of -204.
| Operating Cash Flow | -204 |
| Capital Expenditures | 0 |
| Free Cash Flow | -204 |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TDACU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1.18% |
| FCF Yield | 0% |
Analyst Forecast
Currently there are no analyst rating for TDACU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -325773.05 |
| Piotroski F-Score | 4 |